A leader in High Purity Quartz Exploration in Quebec

A vertically integrated producer of Silicon Metal, Solar Grade Silicon Metal and polysilicon.


BREAKING: Hollister Biosciences Signs Letter of Intent to Acquire Venom Extracts With $16.4 Million In Revenue And $2.48 Million EBITDA


  • Venom is one of Arizona’s premier extract brands and one of the state’s largest producers of award-winning medical cannabis distillate and related products
  • Venom reported having generated CDN$ 16.4 million in revenue and CDN$ 2.48 million in EBIDTA from its product line of Cannabis Concentrates, P.H.O Concentrates and Cartridges

 Hollister large

Read Today's Release

Message: INTERVIEW: HPQ Enters Into Discussions With Li-ion Battery Manufacturer

The headline pretty much says it all.  Though HPQ has stated the discussions are preliminary, this doesn't hide the fact that HPQ has moved incredibly fast from deciding to use its world-changing silicon manufacturing process to enter the battery market.

It was only back on August 19th when Company CEO, Bernard Tourillon, stated HPQ would "start meeting with end users" but few would have expected NDA based discussions with a Li-ion battery manufacturer so soon.  Ironically, Tourillon says he expected something like this "sooner" ... now that is confidence.

In a small cap market full of companies claiming the holy grail of supplying the battery market, it wasn't hard to understand why investors may have dismissed the Company's OCT 31 statement that "HPQ fully intends to use its Gen3 to produce and market silicon materials for batteries".

With discussions under NDA now started with a battery manufacturer, HPQ has now set itself far apart from the pack and has earned the right to be taken very seriously.  Investors who have been waiting for ANY company to move from theoretical to the actual boardroom, HPQ offers a very compelling story.

Grab your favourite beverage and watch this interview with CEO Bernard Tourillon.


New Message
Please login to post a reply